Addiction Science & Clinical Practice (Jan 2021)

Merging statewide data in a public/university collaboration to address opioid use disorder and overdose

  • William C. Becker,
  • Robert Heimer,
  • Catherine M. Dormitzer,
  • Molly Doernberg,
  • Gail D’Onofrio,
  • Lauretta E. Grau,
  • Kathryn Hawk,
  • Hsiu-Ju Lin,
  • Alex M. Secora,
  • David A. Fiellin

DOI
https://doi.org/10.1186/s13722-020-00211-9
Journal volume & issue
Vol. 16, no. 1
pp. 1 – 7

Abstract

Read online

Abstract Objective Describe methods to compile a unified database from disparate state agency datasets linking person-level data on controlled substance prescribing, overdose, and treatment for opioid use disorder in Connecticut. Methods A multidisciplinary team of university, state and federal agency experts planned steps to build the data analytic system: stakeholder engagement, articulation of metrics, funding to establish the system, determination of needed data, accessing data and merging, and matching patient-level data. Results Stakeholder meetings occurred over a 6-month period driving selection of metrics and funding was obtained through a grant from the Food and Drug Administration. Through multi-stakeholder collaborations and memoranda of understanding, we identified relevant data sources, merged them and matched individuals across the merged dataset. The dataset contains information on sociodemographics, treatments and outcomes. Step-by-step processes are presented for dissemination. Conclusions Creation of a unified database linking multiple sources in a timely and ongoing fashion may assist other states to monitor the public health impact of controlled substances, identify and implement interventions, and assess their effectiveness.

Keywords